Answers are grounded in this paper and cite their sources.
This analysis finds improved product safety and quality through risk management in pharmaceuticals, highlighting tools like FMEA and HACCP.
Every product in the pharmaceutical sector has some level of risk. The new guidelines define risk as the sum of the potential the damage will occur and the seriousness of that damage. In order to maximize benefits and balance risk, quality risk management, or QRM, is the comprehensive and ongoing process of reducing risks to product quality throughout its lifecycle. It's the methodical method for assessing, managing, discussing, and reviewing threats to the medication's quality. The pharmaceutical business and regulators can assess, discuss, manage, and analyze risk with the use of QRM technologies. There are numerous preferred approaches for risk management in the pharmaceutical sector, including FMEA, FMECA, FTA, HACCP, HAZOP, PHA, Together, risk rating, filtering, and statistical tool analysis offer high dependability, improved quality, enhanced safety, and cost savings that result in shorter development times, less waste, and fewer non-value-added procedures.5
No takes yet. Share an insight, caveat, or question.
Jadhav et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: